Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100316337 | 10031633 | 7 | F | 201312 | 20160627 | 20140324 | 20160711 | PER | US-PFIZER INC-2013095287 | PFIZER | 72.00 | YR | F | Y | 98.00000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100316337 | 10031633 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75 MG (1 TAB), 2X/DAY | 21446 | 75 | MG | CAPSULE, HARD | BID | ||||||
| 100316337 | 10031633 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | L68170 | 21446 | 75 | MG | CAPSULE, HARD | BID | |||||
| 100316337 | 10031633 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | 21446 | 75 | MG | CAPSULE, HARD | BID | ||||||
| 100316337 | 10031633 | 4 | C | CLONIDINE. | CLONIDINE | 1 | UNK,2X/DAY | 0 | TABLET | BID | |||||||||
| 100316337 | 10031633 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 6 | C | LOSARTAN. | LOSARTAN | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 7 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 8 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | UNK | 0 | ||||||||||
| 100316337 | 10031633 | 10 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 11 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 100316337 | 10031633 | 12 | C | LEVEMIR | INSULIN DETEMIR | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 13 | C | NOVOLOG | INSULIN ASPART | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 14 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 100316337 | 10031633 | 15 | C | INTEGRA | 2 | UNK | 0 | ||||||||||||
| 100316337 | 10031633 | 16 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 17 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 100316337 | 10031633 | 18 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 500 MG, 1X/DAY | P93905 | 0 | 500 | MG | QD | ||||||
| 100316337 | 10031633 | 19 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 90MCG/ACTUATION INHALER: INHALE 2 PUFFS INTO THE LUNGS EVERY 6 (SIX) HOURS AS NEEDED | 0 | |||||||||||
| 100316337 | 10031633 | 20 | C | ZYLOPRIM | ALLOPURINOL | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 100316337 | 10031633 | 21 | C | CATAPRES | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0.1 MG, 3X/DAY | 0 | .1 | MG | TABLET | TID | ||||||
| 100316337 | 10031633 | 22 | C | LOTRISONE | BETAMETHASONE DIPROPIONATECLOTRIMAZOLE | 1 | Topical | UNK, 2X/DAY | 0 | CREAM | BID | ||||||||
| 100316337 | 10031633 | 23 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Intramuscular | 1000 UG/ML, UNK, (INJECT INTO THE MUSCLE EVERY 30 DAYS) | 0 | 1000 | UG | INJECTION | |||||||
| 100316337 | 10031633 | 24 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, 2X/DAY | 0 | 40 | MG | TABLET | BID | ||||||
| 100316337 | 10031633 | 25 | C | LOPID | GEMFIBROZIL | 1 | Oral | 600 MG, DAILY | 0 | 600 | MG | TABLET | |||||||
| 100316337 | 10031633 | 26 | C | LEVEMIR FLEXTOUCH 100 unit/ml (3 ml) InPn | 2 | Subcutaneous | 15 IU, 1X/DAY (INJECT 15 UNITS QHS ) | 0 | 15 | IU | INJECTION | QD | |||||||
| 100316337 | 10031633 | 27 | C | HUMALOG KWIKPEN 100 unit/ml lnPn | 2 | UNK, (INJECT 12 UNITS BREAKFAST, 5 UNITS AT LUNCH, 12 UNITS DINNER+ SS) | 0 | INJECTION | |||||||||||
| 100316337 | 10031633 | 28 | C | INTEGRA F | ASCORBIC ACIDFERROUS ASPARTO GLYCINATEFERROUS FUMARATEFOLIC ACIDNIACIN | 1 | Oral | UNK, DAILY | 0 | ||||||||||
| 100316337 | 10031633 | 29 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, DAILY AS NEEDED | 0 | 10 | MG | TABLET | |||||||
| 100316337 | 10031633 | 30 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | CAPSULE | |||||||
| 100316337 | 10031633 | 31 | C | MIRALAX ORAL | 2 | Oral | UNK, 2X/DAY | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100316337 | 10031633 | 1 | Neuropathy peripheral |
| 100316337 | 10031633 | 4 | Hypertension |
| 100316337 | 10031633 | 5 | Hypertension |
| 100316337 | 10031633 | 18 | Pain |
| 100316337 | 10031633 | 19 | Wheezing |
| 100316337 | 10031633 | 29 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100316337 | 10031633 | Discomfort | |
| 100316337 | 10031633 | Neuropathy peripheral | |
| 100316337 | 10031633 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100316337 | 10031633 | 1 | 201312 | 0 | ||
| 100316337 | 10031633 | 2 | 201507 | 0 | ||
| 100316337 | 10031633 | 18 | 20150915 | 0 |